Skip to Content

TEVA 2050 TEVA 2050 (Tolterodine tartrate extended-release 2 mg)

Pill with imprint TEVA 2050 TEVA 2050 is Green, Capsule-shape and has been identified as Tolterodine tartrate extended-release 2 mg. It is supplied by Teva Pharmaceuticals USA Inc..

Tolterodine is used in the treatment of overactive bladder; urinary incontinence and belongs to the drug class urinary antispasmodics. Risk cannot be ruled out during pregnancy. Tolterodine 2 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for TEVA 2050 TEVA 2050

Tolterodine tartrate extended-release

Imprint:
TEVA 2050 TEVA 2050
Strength:
2 mg
Color:
Green
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Urinary antispasmodics
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Teva Pharmaceuticals USA Inc.
National Drug Code (NDC):
00093-2050

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide